VR Logo

Chimerix Inc. (CMRX) download report


Healthcare | Biotechnology & Pharma Research

Chimerix Inc. (CMRX) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases.

IPO Date: 11-Apr-2013

CEO, Pres & Director: Mr. Michael A. Sherman M.B.A.

Chief Bus. Officer, Sec. & CFO: Mr. Michael T. Andriole M.B.A.

Listing: NASDAQ: CMRX

Country: United States

Headquarters: Durham, NC

Website: https://www.chimerix.com

Key Facts

Market cap: $187.11 Mln

Revenue (TTM): $0.56 Mln

Earnings (TTM): $-100.59 Mln

Cash: $53.38 Mln

Total Debt: $2.26 Mln

Insider's Holding: 4.73%

Liquidity: Low

52 Week range: $1.27 - 8.72

Shares outstanding: 87,436,200

10 Years Aggregate:

  • CFO: $-553.22 Mln
  • EBITDA: $-750.64 Mln
  • Net Profit: $-763.72 Mln

Stock Performance

Time Period Chimerix (CMRX) S&P BSE Sensex S&P Small-Cap 600
YTD-66.72-9.18-18.78
1 month7.54-4.78-8.00
3 months-53.28-9.66-13.65
1 Year-73.250.81-17.19
3 Years-20.8810.336.10
5 Years-17.0511.345.87
10 Years--11.749.84
As on 01-Jul-2022
Year Chimerix (CMRX) S&P Small-Cap 600 S&P BSE Sensex
202133.1325.2721.99
2020137.939.5715.75
2019-21.0120.8614.38
2018-44.31-9.705.87
20170.6511.7327.91
2016-48.6024.741.95
2015-77.77-3.36-5.03